Acinetobacter baumannii

(redirected from Acinetobacter baumanni)

Acinetobacter baumannii

(bou-mä′nē-ī′, -măn′ē-)
n.
A bacterium that causes various infections including pneumonia, meningitis, and wound and urinary tract infections, usually in hospitals and other health care institutions.
References in periodicals archive ?
During the last five decades health care facilities around the globe have experienced the emergence of microorganisms like Methicillin resistant staphylococcus aureus (MRSA), Vancomycin resistant enterococcus (VRE), Extended spectrum beta lactamases (ESBL), Carbapenem resistant Enterobacteriacae (CRE), Carbapenem resistant Acinetobacter baumanni (CRAB) and many more antibiotic resistant microorganisms that microbiologists and clinicians have to memorize the alpha-betical acronyms and abbreviations.
2) Una bacteriemia por Acinetobacter baumanni tratada de manera exitosa con cefepime y tigeciclina.
Base one series of that test and after as compared to characteristic which is worded on guidance book identifies bergey's Of Determinative Bacteriology's Manuals therefore that bacteria gets diidentifikasikan as Acinetobacter baumanni (See figure 3.
Pengaruh Variasi pH dan NaCl Terhadap Produksi Inhibitor Protease yang Dihasilkan oleh Acinetobacter baumanni (Bakteri yang Berasosiasi dengan Spons Plakortis nigra).
Five of the bacteria identified in this study had not been reported previously associated with house flies: Acinetobacter baumanni, Bacillus pumilus, Cronobacter sakazakii, Methylobacterium persicinum, and Staphylococcus sciuri.
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumanni.
aeruginosa, Acinetobacter baumanni and Stenotrophomonas maltophilia12.
Prevalence of antibiotic - resistant Acinetobacter baumanni in a 1000 - bed tertiary care hospital in Tehran, Iran.
Antibiotic resistance reflects exclusive use of antibiotic Acinetobacter baumanni is increasingly responsible for a large number of infections.
2) In recent years, Acinetobacter baumanni has become a worldwide concern as a cause of serious nosocomial infections.
Resistance rates to 15 different antimicrobials of the Acinetobacter baumanni and Pseudomonas aeruginosa strains isolated from patients with and without MVAP are shown in Figs.
Treatment of multi-drug-resistant Acinetobacter baumanni VAP with intravenous colistin: a comparison with imipenamsusceptible VAP.